Back to Find a Doctor
Dr. Joel A. Okoli

Dr. Joel A. Okoli, MD, MPH, FACS

Dr. Joel A. Okoli, MD is a General Surgery Specialist in Atlanta and has more than 39 years of experience in the medical field. He graduated from Yale University School of Medicine medical school in 1981. As a general surgeon in Atlanta, Dr. Joel A. Okoli performs surgical procedures to treat conditions affecting the abdomen and related structures, like hernias or tumors.


  • Surgery

Board Certifications

  • ABMS Surgery


  • Morehouse

Education & Training

  • Medical School: Yale University School of Medicine
  • Internship: Kaleida Buffalo General Hospital
  • Residency: Kaleida Buffalo General Hospital


Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery. Binkley, J. M., Stratford, P. W., Kirkpatrick, S., Farley, C. R., Okoli, J., Gabram, S.

Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital. Jones, V., Linebarger, J. H., Perez, S. D., Gabram, S., Okoli, J., Bumpers, H. L., Burns, B., Mosunjac, M., Rizzo, M.

Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Bowman, E., Oprea, G., Okoli, J., Gundry, K., Rizzo, M., Gabram-Mendola, S., Manne, U., Smith, G., Pambuccian, S. E., Bumpers, H. L.

Improving on national quality indicators of breast cancer care in a large public hospital as a means to decrease disparities for African American women.Rizzo, M., Bumpers, H. L., Okoli, J., Senior-Crosby, D., O'Regan, R., Zelnak, A., Pan, L., Mosunjac, M., Patterson, S. G., Gabram, S. G.

Using National Quality Forum breast cancer indicators to measure quality of care for patients in an AVON comprehensive breast center. Iyengar, R., Lund, M. J., Lamson, P., Holmes, L., Rizzo, M., Bumpers, H. L., Okoli, J., Senior-Crosby, D., O'Regan, R., Gabram, S. G.

Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Gabram, S. G., Lund, M. J., Gardner, J., Hatchett, N., Bumpers, H. L., Okoli, J., Rizzo, M., Johnson, B. J., Kirkpatrick, G. B., Brawley, O. W.

High prevalence of triple-negative tumors in an urban cancer center. Lund, M. J., Butler, E. N., Bumpers, H. L., Okoli, J., Rizzo, M., Hatchett, N., Green, V. L., Brawley, O. W., Oprea-Ilies, G. M., Gabram, S. G.

Abnormal mammogram follow-up: do community lay health advocates make a difference? Crump, S. R., Shipp, M. P., McCray, G. G., Morris, S. J., Okoli, J. A., Caplan, L. S., Thorne, S. L., Blumenthal, D. S.

BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers. Yuli, C., Shao, N., Rao, R., Aysola, P., Reddy, V., Oprea-llies, G., Lee, L., Okoli, J., Partridge, E., Reddy, E. S., Rao, V. N.

Effects of HIV-1 Nef, a cytotoxic viral protein, on the growth of primary colorectal cancer. Bumpers, H. L., Huang, M., Powell, M., Grizzle, W. E., Lillard, J. W., Okoli, J., Bond, V. C.

Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Aikhionbare, F. O., Khan, M., Carey, D., Okoli, J., Go, R. C.